Table 2.
Breast Cancer Recurrence | Breast Cancer-Specific Mortality | All-Cause Mortality | Disease Free Survival | |||||
---|---|---|---|---|---|---|---|---|
Crude HR (95% CI) | Adjusted HR¥ (95% CI) | Crude HR (95% CI) | Adjusted HR¥ (95% CI) | Crude HR (95% CI) | Adjusted HR¥ (95% CI) | Crude HR (95% CI) | Adjusted HR¥ (95% CI) | |
| ||||||||
Indigenous American Ancestry* | 1.00 (0.86, 1.16) | 0.98 (0.84, 1.15) | 0.95 (0.77, 1.17) | 0.97 (0.78, 1.19) | 0.93 (0.80, 1.08) | 0.98 (0.83, 1.14) | 0.96 (0.85, 1.08) | 0.98 (0.87, 1.10) |
Age at Diagnosis | 0.99 (0.96, 1.00) | 1.00 (0.98, 1.03) | 1.02 (1.00, 1.04) | 1.01 (1.00, 1.03) | ||||
AJCC Stage | ||||||||
Stage I–II | ref | ref | ref | ref | ||||
Stage III–IV | 4.01 (2.3, 7.1) | 7.35 (3.60, 15.0) | 4.61 (2.65, 8.03) | 3.65 (2.31, 5.76) | ||||
Hormonal Therapy | ||||||||
No | ref | ref | ref | ref | ||||
Yes | 0.56 (0.32, 0.97) | 0.49 (0.24, 1.00) | 0.39 (0.23, 0.66) | 0.57 (0.37, 0.88) |
Per 10% increase in ancestry
Adjusted for age at diagnosis (years), AJCC stage and hormonal therapy.